0000899243-20-009975.txt : 20200402 0000899243-20-009975.hdr.sgml : 20200402 20200402152851 ACCESSION NUMBER: 0000899243-20-009975 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200331 FILED AS OF DATE: 20200402 DATE AS OF CHANGE: 20200402 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Misfeldt Dayton CENTRAL INDEX KEY: 0001461466 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51531 FILM NUMBER: 20768694 MAIL ADDRESS: STREET 1: C/O BAY CITY CAPITAL LLC STREET 2: 750 BATTERY STREET, SUITE 400 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SUNESIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001061027 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943295878 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 395 OYSTER POINT BOULEVARD STREET 2: SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-266-3500 MAIL ADDRESS: STREET 1: 395 OYSTER POINT BOULEVARD STREET 2: SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: MOSAIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 19980709 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-03-31 0 0001061027 SUNESIS PHARMACEUTICALS INC SNSS 0001461466 Misfeldt Dayton SUNESIS PHARMACEUTICALS, INC. 395 OYSTER POINT BOULEVARD, STE. 400 SOUTH SAN FRANCISCO CA 94080 1 1 0 0 Interim CEO Stock Option (Right to Buy) 0.4149 2020-03-31 4 A 0 480000 0.00 A 2030-03-31 Common Stock 480000 480000 D The option vests monthly over six (6) months from the date of grant subject to the optionee's continued service to the Company. /s/William P. Quinn (Attorney-in-Fact) 2020-04-02